Comparison of intra nasal lidocaine 10% & lidocaine 5% for headache relief in head trauma

Comparison of intra nasal lidocaine 10% & lidocaine 5% for headache relief in head trauma patients referring to emergency department

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20181103041539N1

Enrollment

Registered

2018-12-23

Start date

2018-11-11

Completion date

Unknown

Last updated

2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

head trauma. Headache

Interventions

Intervention 1: Intervention group: Group A administered 5% lidocaine spray administered intranasal. Intervention 2: Control group: Group B administered 10% lidocaine.

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patients with head trauma who do not have an Exclusion Criteria

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Headache score for patients. Timepoint: Headache score for patients with head trauma at 0, 5, 15, 30 and 60 minutes after medication administration. Method of measurement: numeric pain rating scale.	—

Secondary

Measure	Time frame
Patient Satisfaction. Timepoint: After an hour of medication administration. Method of measurement: Visual Analogue Scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Tabatabaei

Yazd University of Medical Sciences

F.tabatabaei@ssu.ac.ir+98 35 3833 5990

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026